Toronto Dominion Bank’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$57.3M Sell
116,473
-87,890
-43% -$47.7M 0.08% 218
2025
Q4
$118M Buy
204,363
+56,869
+39% +$32.2M 0.17% 114
2025
Q3
$71.4M Sell
147,494
-203,817
-58% -$94.9M 0.11% 176
2025
Q2
$142M Buy
351,311
+162,066
+86% +$67.8M 0.24% 78
2025
Q1
$94.2M Sell
189,245
-20,386
-10% -$11M 0.18% 99
2024
Q4
$109M Buy
209,631
+16,060
+8% +$8.83M 0.17% 85
2024
Q3
$120M Sell
193,571
-9,981
-5% -$5.91M 0.21% 66
2024
Q2
$113M Sell
203,552
-125,373
-38% -$71.8M 0.18% 72
2024
Q1
$191M Buy
328,925
+95,643
+41% +$53.7M 0.3% 49
2023
Q4
$124M Buy
233,282
+18,163
+8% +$8.79M 0.18% 89
2023
Q3
$109M Sell
215,119
-7,149
-3% -$3.81M 0.18% 93
2023
Q2
$116M Sell
222,268
-70,920
-24% -$38.3M 0.17% 99
2023
Q1
$169M Sell
293,188
-34,645
-11% -$19.5M 0.28% 65
2022
Q4
$180M Buy
327,833
+56,054
+21% +$29.7M 0.27% 63
2022
Q3
$138M Sell
271,779
-54,283
-17% -$30.4M 0.25% 63
2022
Q2
$177M Sell
326,062
-38,518
-11% -$21.2M 0.33% 48
2022
Q1
$215M Buy
364,580
+56,544
+18% +$32.5M 0.33% 49
2021
Q4
$206M Buy
308,036
+18,717
+6% +$11.7M 0.27% 61
2021
Q3
$165M Sell
289,319
-81,440
-22% -$44.7M 0.26% 60
2021
Q2
$187M Sell
370,759
-16,171
-4% -$7.63M 0.29% 58
2021
Q1
$177M Buy
386,930
+43,911
+13% +$21M 0.31% 54
2020
Q4
$160M Buy
343,019
+93,059
+37% +$43.6M 0.29% 60
2020
Q3
$110M Sell
249,960
-30,762
-11% -$12.7M 0.27% 67
2020
Q2
$102M Sell
280,722
-33,217
-11% -$11.1M 0.26% 68
2020
Q1
$89M Sell
313,939
-78,361
-20% -$24.7M 0.27% 70
2019
Q4
$127M Buy
392,300
+93,133
+31% +$28.2M 0.21% 82
2019
Q3
$87.1M Sell
299,167
-267,119
-47% -$76.5M 0.18% 89
2019
Q2
$83.2M Buy
566,286
+281,599
+99% +$77.6M 0.18% 87
2019
Q1
$77.9M Buy
284,687
+29,029
+11% +$7.22M 0.12% 106
2018
Q4
$57.2M Sell
255,658
-15,125
-6% -$3.55M 0.1% 106
2018
Q3
$66.1M Buy
270,783
+7,166
+3% +$1.65M 0.12% 115
2018
Q2
$54.6M Buy
263,617
+31,897
+14% +$6.77M 0.11% 127
2018
Q1
$47.8M Buy
231,720
+8,878
+4% +$1.86M 0.11% 104
2017
Q4
$42.3M Buy
222,842
+17,462
+9% +$3.35M 0.13% 106
2017
Q3
$38.9M Buy
205,380
+71,103
+53% +$12.9M 0.12% 100
2017
Q2
$23.4M Buy
134,277
+27,178
+25% +$4.57M 0.07% 159
2017
Q1
$16.4M Buy
107,099
+37,307
+53% +$5.7M 0.04% 186
2016
Q4
$9.85M Buy
69,792
+56,604
+429% +$8.35M 0.03% 195
2016
Q3
$2.1M Buy
13,188
+9,281
+238% +$1.43M 0.01% 300
2016
Q2
$579K Sell
3,907
-854
-18% -$126K ﹤0.01% 418
2016
Q1
$673K Sell
4,761
-9,639
-67% -$1.29M ﹤0.01% 334
2015
Q4
$2.04M Sell
14,400
-424
-3% -$56.6K 0.01% 241
2015
Q3
$1.81M Buy
14,824
+1,079
+8% +$141K 0.01% 249
2015
Q2
$1.78M Buy
13,745
+72
+0.5% +$9.39K 0.01% 295
2015
Q1
$1.84M Sell
13,673
-5,782
-30% -$745K 0.01% 290
2014
Q4
$2.44M Buy
19,455
+8,764
+82% +$1.07M 0.01% 274
2014
Q3
$917K Buy
10,691
+664
+7% +$80.7K ﹤0.01% 386
2014
Q2
$1.18M Buy
10,027
+1,272
+15% +$150K ﹤0.01% 355
2014
Q1
$1.06M Buy
8,755
+487
+6% +$57.9K ﹤0.01% 354
2013
Q4
$920K Buy
8,268
+5,768
+231% +$574K ﹤0.01% 356
2013
Q3
$230K Buy
2,500
+1,035
+71% +$93.6K ﹤0.01% 484
2013
Q2
$124K Buy
+1,465
New +$122K ﹤0.01% 559

Other funds holding TMO

Toronto Dominion Bank's TMO Position: Q1 2026 in Review

Toronto Dominion Bank reduced its Thermo Fisher Scientific (TMO) stake by 43% in Q1 2026, selling an estimated $47.7M and leaving 116,473 shares worth $57.3M. The position accounts for 0.08% of the portfolio, ranked #218.

Toronto Dominion Bank first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $215M in Q1 2022. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Toronto Dominion Bank held 116,473 shares of Thermo Fisher Scientific worth $57.3M as of Q1 2026.
  • Toronto Dominion Bank sold 87,890 Thermo Fisher Scientific shares in Q1 2026, an estimated $47.7M.
  • Thermo Fisher Scientific made up 0.08% of Toronto Dominion Bank's portfolio in Q1 2026, its #218 holding.
  • Toronto Dominion Bank first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
  • Toronto Dominion Bank's Thermo Fisher Scientific position peaked at $215M in Q1 2022.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.